The Human Medicines (Amendment) Regulations 2019
Typestatutory instrumentDate14 Jan 2019Articles19Cited by4 documents
- Preamble
- 1Citation and commencement
- 2Amendment of the Human Medicines Regulations 2012
- 3Amendment of regulation 8 (general interpretation)
- 4Amendment of regulation 36 (conditions for manufacturer’s licence)
- 5Amendment of Regulation 39 (further requirements for manufacturer’s licence)
- 6Amendment of regulation 42 (conditions for wholesale dealer’s licence)
- 7Insertion of regulation 43A (requirement for wholesale dealers to decommission the unique identifier)
- 8Insertion of regulation 94A (offences relating to Commission Regulation 2016/161)
- 9Insertion of regulation 226A (sale etc by a pharmacist in accordance with a serious shortage protocol)
- 10Insertion of regulations 255A to 255C
- 11Insertion of regulation 257A and 257B
- 12Amendment of regulation 268 (enforcement relating to packaging and package leaflets: holder of authorisatio
- 13Amendment of regulation 269 (offences relating to packaging and package leaflets: other persons)
- 14Amendment of regulation 323 (enforcement in England, Wales and Scotland)
- 15Amendment of regulation 327 (powers of inspection, sampling and seizure)
- 16Amendment of regulation 346 (Secretary of State to carry out a review of certain provisions)
- 17Amendment of Schedule 7 (qualified persons)
- 18Amendment of Schedule 17 (exemption for sale, supply or administration by certain persons)
- 19Amendment of Schedule 24 (packaging information requirements)
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.